Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

monoclonal antibody targeting B-lymphocyte stimulator for autoimmune conditions

Belimumab is a monoclonal antibody that inhibits the activity of B-lymphocyte stimulator (BLyS), a protein involved in the survival and proliferation of B cells. It is primarily used in the treatment of systemic lupus erythematosus (SLE) but has gained attention for its potential role in hair loss conditions, particularly in cases of autoimmune-related alopecia. By modulating the immune response, belimumab may help reduce inflammation and promote hair regrowth in individuals experiencing hair loss due to autoimmune disorders. Its distinguishing characteristic is its targeted action on the immune system, differentiating it from other hair loss treatments that focus on hormonal or topical interventions.

Related Terms

• Golimumab
• Adalimumab
• Dupilumab
• Secukinumab
• Baricitinib
• Nivolumab
• Infliximab
• Rituximab